Cargando…
Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial
PURPOSE: We compared the predictive accuracy of early-phase brain diffusion tensor imaging (DTI), proton magnetic resonance spectroscopy (1H-MRS), and serum neuron-specific enolase (NSE) against the motor score and epileptic seizures (ES) for poor neurological outcome after out-of-hospital cardiac a...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859870/ https://www.ncbi.nlm.nih.gov/pubmed/36251060 http://dx.doi.org/10.1007/s00234-022-03063-z |
_version_ | 1784874456179539968 |
---|---|
author | Koskensalo, Kalle Virtanen, Sami Saunavaara, Jani Parkkola, Riitta Laitio, Ruut Arola, Olli Hynninen, Marja Silvasti, Päivi Nukarinen, Eija Martola, Juha Silvennoinen, Heli M. Tiainen, Marjaana Roine, Risto O. Scheinin, Harry Saraste, Antti Maze, Mervyn Vahlberg, Tero Laitio, Timo T. |
author_facet | Koskensalo, Kalle Virtanen, Sami Saunavaara, Jani Parkkola, Riitta Laitio, Ruut Arola, Olli Hynninen, Marja Silvasti, Päivi Nukarinen, Eija Martola, Juha Silvennoinen, Heli M. Tiainen, Marjaana Roine, Risto O. Scheinin, Harry Saraste, Antti Maze, Mervyn Vahlberg, Tero Laitio, Timo T. |
author_sort | Koskensalo, Kalle |
collection | PubMed |
description | PURPOSE: We compared the predictive accuracy of early-phase brain diffusion tensor imaging (DTI), proton magnetic resonance spectroscopy (1H-MRS), and serum neuron-specific enolase (NSE) against the motor score and epileptic seizures (ES) for poor neurological outcome after out-of-hospital cardiac arrest (OHCA). METHODS: The predictive accuracy of DTI, 1H-MRS, and NSE along with motor score at 72 h and ES for the poor neurological outcome (modified Rankin Scale, mRS, 3 − 6) in 92 comatose OHCA patients at 6 months was assessed by area under the receiver operating characteristic curve (AUROC). Combined models of the variables were included as exploratory. RESULTS: The predictive accuracy of fractional anisotropy (FA) of DTI (AUROC 0.73, 95% CI 0.62–0.84), total N-acetyl aspartate/total creatine (tNAA/tCr) of 1H-MRS (0.78 (0.68 − 0.88)), or NSE at 72 h (0.85 (0.76 − 0.93)) was not significantly better than motor score at 72 h (0.88 (95% CI 0.80–0.96)). The addition of FA and tNAA/tCr to a combination of NSE, motor score, and ES provided a small but statistically significant improvement in predictive accuracy (AUROC 0.92 (0.85–0.98) vs 0.98 (0.96–1.00), p = 0.037). CONCLUSION: None of the variables (FA, tNAA/tCr, ES, NSE at 72 h, and motor score at 72 h) differed significantly in predicting poor outcomes in this patient group. Early-phase quantitative neuroimaging provided a statistically significant improvement for the predictive value when combined with ES and motor score with or without NSE. However, in clinical practice, the additional value is small, and considering the costs and challenges of imaging in this patient group, early-phase DTI/MRS cannot be recommended for routine use. TRIAL REGISTRATION: ClinicalTrials.gov NCT00879892, April 13, 2009. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00234-022-03063-z. |
format | Online Article Text |
id | pubmed-9859870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-98598702023-01-22 Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial Koskensalo, Kalle Virtanen, Sami Saunavaara, Jani Parkkola, Riitta Laitio, Ruut Arola, Olli Hynninen, Marja Silvasti, Päivi Nukarinen, Eija Martola, Juha Silvennoinen, Heli M. Tiainen, Marjaana Roine, Risto O. Scheinin, Harry Saraste, Antti Maze, Mervyn Vahlberg, Tero Laitio, Timo T. Neuroradiology Functional Neuroradiology PURPOSE: We compared the predictive accuracy of early-phase brain diffusion tensor imaging (DTI), proton magnetic resonance spectroscopy (1H-MRS), and serum neuron-specific enolase (NSE) against the motor score and epileptic seizures (ES) for poor neurological outcome after out-of-hospital cardiac arrest (OHCA). METHODS: The predictive accuracy of DTI, 1H-MRS, and NSE along with motor score at 72 h and ES for the poor neurological outcome (modified Rankin Scale, mRS, 3 − 6) in 92 comatose OHCA patients at 6 months was assessed by area under the receiver operating characteristic curve (AUROC). Combined models of the variables were included as exploratory. RESULTS: The predictive accuracy of fractional anisotropy (FA) of DTI (AUROC 0.73, 95% CI 0.62–0.84), total N-acetyl aspartate/total creatine (tNAA/tCr) of 1H-MRS (0.78 (0.68 − 0.88)), or NSE at 72 h (0.85 (0.76 − 0.93)) was not significantly better than motor score at 72 h (0.88 (95% CI 0.80–0.96)). The addition of FA and tNAA/tCr to a combination of NSE, motor score, and ES provided a small but statistically significant improvement in predictive accuracy (AUROC 0.92 (0.85–0.98) vs 0.98 (0.96–1.00), p = 0.037). CONCLUSION: None of the variables (FA, tNAA/tCr, ES, NSE at 72 h, and motor score at 72 h) differed significantly in predicting poor outcomes in this patient group. Early-phase quantitative neuroimaging provided a statistically significant improvement for the predictive value when combined with ES and motor score with or without NSE. However, in clinical practice, the additional value is small, and considering the costs and challenges of imaging in this patient group, early-phase DTI/MRS cannot be recommended for routine use. TRIAL REGISTRATION: ClinicalTrials.gov NCT00879892, April 13, 2009. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00234-022-03063-z. Springer Berlin Heidelberg 2022-10-17 2023 /pmc/articles/PMC9859870/ /pubmed/36251060 http://dx.doi.org/10.1007/s00234-022-03063-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Functional Neuroradiology Koskensalo, Kalle Virtanen, Sami Saunavaara, Jani Parkkola, Riitta Laitio, Ruut Arola, Olli Hynninen, Marja Silvasti, Päivi Nukarinen, Eija Martola, Juha Silvennoinen, Heli M. Tiainen, Marjaana Roine, Risto O. Scheinin, Harry Saraste, Antti Maze, Mervyn Vahlberg, Tero Laitio, Timo T. Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial |
title | Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial |
title_full | Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial |
title_fullStr | Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial |
title_full_unstemmed | Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial |
title_short | Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial |
title_sort | comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the xehypotheca trial |
topic | Functional Neuroradiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859870/ https://www.ncbi.nlm.nih.gov/pubmed/36251060 http://dx.doi.org/10.1007/s00234-022-03063-z |
work_keys_str_mv | AT koskensalokalle comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT virtanensami comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT saunavaarajani comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT parkkolariitta comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT laitioruut comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT arolaolli comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT hynninenmarja comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT silvastipaivi comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT nukarineneija comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT martolajuha comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT silvennoinenhelim comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT tiainenmarjaana comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT roineristoo comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT scheininharry comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT sarasteantti comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT mazemervyn comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT vahlbergtero comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT laitiotimot comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial AT comparisonoftheprognosticvalueofearlyphaseprotonmagneticresonancespectroscopyanddiffusiontensorimagingwithserumneuronspecificenolaseat72hincomatosesurvivorsofoutofhospitalcardiacarrestasubstudyofthexehypothecatrial |